BCYC
Price
$6.47
Change
-$0.15 (-2.27%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
459.91M
47 days until earnings call
Intraday BUY SELL Signals
LENZ
Price
$18.15
Change
-$0.44 (-2.37%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
581.68M
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs LENZ

Header iconBCYC vs LENZ Comparison
Open Charts BCYC vs LENZBanner chart's image
Bicycle Therapeutics
Price$6.47
Change-$0.15 (-2.27%)
Volume$2.4K
Capitalization459.91M
LENZ Therapeutics
Price$18.15
Change-$0.44 (-2.37%)
Volume$15.39K
Capitalization581.68M
BCYC vs LENZ Comparison Chart in %
BCYC
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCYC vs. LENZ commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (BCYC: $6.62 vs. LENZ: $18.59)
Brand notoriety: BCYC and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 72% vs. LENZ: 163%
Market capitalization -- BCYC: $448.81M vs. LENZ: $567.6M
BCYC [@Biotechnology] is valued at $448.81M. LENZ’s [@Biotechnology] market capitalization is $567.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileLENZ’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and LENZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 2 TA indicator(s) are bullish while LENZ’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 2 bullish, 5 bearish.
  • LENZ’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -3.64% price change this week, while LENZ (@Biotechnology) price change was +13.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($582M) has a higher market cap than BCYC($460M). LENZ YTD gains are higher at: 16.188 vs. BCYC (-6.497). LENZ has higher annual earnings (EBITDA): -67.7M vs. BCYC (-245.86M). BCYC has more cash in the bank: 648M vs. LENZ (202M). LENZ has less debt than BCYC: LENZ (954K) vs BCYC (5.74M). BCYC has higher revenues than LENZ: BCYC (28.3M) vs LENZ (17.5M).
BCYCLENZBCYC / LENZ
Capitalization460M582M79%
EBITDA-245.86M-67.7M363%
Gain YTD-6.49716.188-40%
P/E RatioN/A48.03-
Revenue28.3M17.5M162%
Total Cash648M202M321%
Total Debt5.74M954K602%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCLENZ
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WFSAX27.70-0.04
-0.14%
Allspring Small Company Growth A
LRAGX18.04-0.03
-0.17%
Lord Abbett International Growth R3
AFCNX19.57-0.06
-0.31%
American Century Focused Intl Gr Inv
AGRCX128.75-1.73
-1.33%
AB Growth C
PRGTX27.09-0.37
-1.35%
T. Rowe Price Global Technology

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with NRIX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+2.00%
NRIX - BCYC
52%
Loosely correlated
+0.58%
RGNX - BCYC
50%
Loosely correlated
-0.66%
XNCR - BCYC
50%
Loosely correlated
+3.66%
NGNE - BCYC
50%
Loosely correlated
+10.91%
SYRE - BCYC
49%
Loosely correlated
+5.17%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BCYC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+11.99%
BCYC - LENZ
40%
Loosely correlated
+2.00%
BHVN - LENZ
39%
Loosely correlated
+6.65%
MLTX - LENZ
37%
Loosely correlated
+1.81%
CELC - LENZ
36%
Loosely correlated
+9.86%
XNCR - LENZ
34%
Loosely correlated
+3.66%
More